Business brief
Quantum Bet, Pharma Pivot, and Clean-Tech Pressures
Israeli corporates reshape global footprints as Intel acquires Classiq, Teva expands branded neuroscience, and solar developers pivot abroad.
Business
Intel's $2.3B takeover of Classiq establishes Tel Aviv as its global quantum computing center — replacing traditional silicon scaling with post-binary computing architectures.
BackgroundQuantum computing harnesses the strange physics of subatomic particles to solve mathematical calculations that would overwhelm conventional silicon processors. Intel has operated design and manufacturing centers across Israel for 50 years, with Classiq marking its largest local buyout since Mobileye.
- Co-founders Nir Minerbi and Yehuda Naveh will run Intel's international quantum software compiler operations directly from Tel Aviv, preserving local leadership over the core architecture.
- Classiq's 150 local software engineers will share up to $450M in vested equity proceeds, delivering a rare large-scale payout for an Israeli deep-tech software team.
- Venture investors at the TECH1 summit cited the deal as proof that deep-tech software platforms can secure premium multinational exits without moving headquarters overseas.
Business
SolarEdge's fifth round of job cuts reflects persistent rooftop solar weakness — forcing the inverter pioneer to pivot toward AI data centers to stem cash bleed.
BackgroundSolarEdge builds smart inverters and residential storage systems that convert raw solar panel voltage into usable grid electricity. Elevated borrowing costs and scaled-back European rooftop subsidies cooled consumer installations, leaving distributors with warehouses of unsold hardware.
- The restructuring eliminates up to 60 engineering and corporate roles at SolarEdge's central research campus in Herzliya, narrowing domestic headcount.
- The company previously shuttered its energy storage cell manufacturing unit in South Korea to halt operating cash burn and preserve liquidity.
- Executives are pitching high-voltage direct-current power architectures directly to artificial intelligence data center builders to offset slumping residential solar volumes.
Business
Teva's buyout of BioXcel's agitation treatment accelerates its corporate turnaround — swapping commoditized generic drugs for proprietary, high-margin neuropsychiatric therapies.
BackgroundSublingual films dissolve under the tongue to deliver rapid medication into the bloodstream without requiring injections or swallowed pills during psychiatric emergencies. Petah Tikva-based Teva is pivoting from low-margin generic copies toward proprietary branded drugs that command sustained pricing power.
- BXCL501 is under priority review at the US FDA for treating acute neuropsychiatric agitation in at-home clinical settings, bypassing emergency room visits.
- If cleared by regulators, the sublingual film would become the first self-administered therapy authorized for acute agitation in schizophrenia and bipolar disorders.
- Teva will market the drug through its established North American hospital sales force, pairing it with existing neuropsychiatry treatments like Austedo to lift commercial margins.
Business
Grid bottlenecks inside Israel are driving domestic developers like Doral into the US Midwest — securing institutional yield through hyperscale clean-power contracts.
BackgroundUtility-scale solar projects generate bulk electricity directly for power grids rather than individual buildings, requiring thousands of rural acres and high-voltage transmission lines. Inside Israel, severe grid bottlenecks and land scarcity have capped local expansion, pushing developers toward US utility markets.
- Doral secured combined debt financing from Israeli pension managers and global development lenders to complete construction phases across 13,000 Indiana acres.
- Mammoth Solar will rank among the largest solar installations in the Western Hemisphere once all generation phases synchronize to the regional power transmission grid.
- The project anchors long-term power purchase contracts with hyperscale cloud operators hungry for round-the-clock green electrons to supply Midwestern artificial intelligence facilities.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
